Navigation Links
Late peak may have prevented severe flu season from becoming worse

The 2004-2005 flu season was at least as severe as the 2003-2004 season, but peaked later according to data from Solucient, a leading provider of healthcare information. This later peak may have prevented the most recent flu season from being even worse.

A flu season's severity is reflected in hospital admissions for community-acquired pneumonia (CAP), one of the most common complications of the flu. Solucient analyzed CAP discharge data from October 2002 through March 2005. The data was provided by ACTrackerTM, an online tool that provides national estimates of hospital and drug utilization approximately 45 days after the end of each month, making the estimates the most timely and current of their kind.

In the 2004-2005 flu season, daily CAP discharges peaked at an average of about 7,000 and 8,000, respectively, in January/February 2005 compared to the previous flu season's December 2003/January 2004 peak. Both these seasons had approximately 31 percent more hospital discharges than the 2002-2003 flu season.

Due to an unusual shortage of flu vaccine, the later peak of the 2004-2005 flu season may have been beneficial, allowing public health officials more time to reallocate and administer the limited supply of vaccine to those most in need -- the elderly and children. This extra time could have been responsible for preventing many more people from becoming ill than would have been expected under the circumstances if the flu peaked at the same time it did the year before.

###

To see a graph showing hospital CAP admissions for 2002-2005, go to http://www.solucient.com/trendtracker


'"/>

Source:Solucient, LLC


Page: 1

Related biology news :

1. Study reveals genomics of inflammation from severe injury
2. Study shows pine bark naturally decreases severe chronic venous insufficiency
3. New treatment for severe malaria
4. Highly concentrated botulinum preparation for cosmetic injections can result in severe illness
5. Hopkins scientists link immune response to ghost parasites and severely congested sinuses
6. New findings could lead to vaccine for severe malaria
7. MRSA toxin acquitted: Study clears suspected key to severe bacterial illness
8. Mutant gene causes severe kidney disease in infants
9. Stanford-led study closes in on genes that may predispose some people to severe depression
10. Amazon rainforest greens up in the dry season
11. Air travel and flu: Post-9/11 restrictions delayed start of season
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/16/2016)... , Dec. 16, 2016   IdentyTechSolutions America ... management products and solutions and a cutting-edge manufacturer ... that it is offering seamless, integrated solutions that ... entrance products. The solutions provide IdentyTech,s customers with ... their facilities from crime and theft. ...
(Date:12/16/2016)... NEW YORK , Dec. 16, 2016 The global ... reach USD 12.14 billion by 2021 from USD 5.31 billion in ... ... market is mainly driven by technological advancements in medical devices, launch ... devices, rising preference for wireless connectivity among healthcare providers, and increasing ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... ... January 21, 2017 , ... Nova Oculus Partners has ... pioneering medical device for the treatment of Age-Related Macular Degeneration. , The company’s ... global regulatory consultancy that helps companies like ours secure government approvals for their ...
(Date:1/21/2017)... 20, 2017 Aratana Therapeutics, Inc. (NASDAQ: ... the licensing, development and commercialization of innovative biopharmaceutical products ... Company in North America 2016. ... based on the FDA approval of three innovative ... ® (capromorelin oral solution) and NOCITA ® ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... how current market conditions have influenced the most recent ... Regulus Therapeutics Inc. (NASDAQ: RGLS ), Abeona ... Inc. (NASDAQ: TBPH ), and Sage Therapeutics ... new research report by Grand View Research, global Biotech market size ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... Technologies, announced today the next evolution in spinal fusion, the MISquito Percutaneous ... contrast to the competition, SpineFrontier is focused on technique driven product solutions ...
Breaking Biology Technology: